COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160009723A1
SERIAL NO

14800029

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to pyrrolopyrazines compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VERTEX PHARMACEUTICALS INCORPORATEDBOSTON MA 02210

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Charrier, Jean-Damien Abingdon, GB 173 5993
Durrant, Steven John Abingdon, GB 32 1576
Fraysse, Damien Abingdon, GB 66 1554
Knegtel, Ronald Marcellus Alphonsus Abingdon, GB 21 738
MacCormick, Somhairle Abingdon, GB 23 984
Pinder, Joanne Abingdon, GB 55 2170
Reaper, Philip Michael Abingdon, GB 32 1089
Virani, Anisa Nizarali Abingdon, GB 18 608

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation